Seelos Therapeutics, Inc. (SEEL) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Seelos Therapeutics, Inc., with annual and quarterly history.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -22.85x | -121.39x | -280.80x | -471.05x | -69.14x | -515.79x |
| P/B Ratio | -25.83x | -871.02x | 330.81x | 3520.06x | -497623.63x | 1853.41x |
| P/S Ratio | 392.91x | 0.00x | 0.00x | 0.00x | 9288.97x | 0.00x |
| Profitability | ||||||
| Gross Margin | -1267.1% | 0.0% | 0.0% | 0.0% | -5916.8% | 0.0% |
| Operating Margin | -1838.4% | 0.0% | 0.0% | 0.0% | -7932.5% | 0.0% |
| Net Margin | -1719.6% | 0.0% | 0.0% | 0.0% | -13435.5% | 0.0% |
| EBITDA Margin | -1713.6% | 0.0% | 0.0% | 0.0% | -7821.3% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 0.14x | 0.90x | 10.07x | 2.35x | 1.03x | 3.14x |
| Quick Ratio | 0.14x | 0.90x | 10.07x | 2.35x | 1.03x | 3.14x |
| Leverage | ||||||
| Debt/Equity | -0.42x | -1.90x | 0.33x | 3.78x | 0.00x | 0.95x |
YoY = year-over-year change. Source: FMP..